Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers July 23, 2017
Pharmacy Choice - Pharmaceutical News - Argentum Pharmaceuticals and Allergan Settle Patent Dispute Over RESTASIS - July 23, 2017

Pharmacy News Article

 4/18/17 - Argentum Pharmaceuticals and Allergan Settle Patent Dispute Over RESTASIS

NEW YORK, April 18, 2017 /PRNewswire/ Argentum Pharmaceuticals LLC, a generic pharmaceutical company, announced that it has reached a settlement and license agreement with Allergan, Inc. related to Argentum's generic version of RESTASIS (0.05% cyclosporine ophthalmic emulsion).

The agreement generally provides that Argentum may commence marketing its generic equivalent product sometime prior to the expiration of the patents covering RESTASIS. The specific date on which Argentum may launch its generic product and other details concerning the settlement have not been disclosed.

RESTASIS is a registered trademark of Allergan, Inc.

To view the original version on PR Newswire, visit:

SOURCE Argentum Pharmaceuticals

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Jul 23: REMS Drugs & The Practice of Pharmacy: A Program in Law and Risk Management
Last Chance
Jul 24: What's New? New Treatments for Type 2 Diabetes
Jul 26: Management of Schizophrenia & Acute Agitation
Jul 27: On the Move: A Comprehensive Review of Osteoarthritis, Gout & Rheumatoid Arthritis
Jul 31: Obesity Management: Overview of Pharmacotherapy
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement